Yahoo Web Search

Search results

1. • 

     First person with MS to play in the NBA shares his inspiring message: 'Make the most of it'

     Fox News via Yahoo News· 2 days ago

     Ahead of World MS Day, former NBA player Chris Wright and his neurologist, Dr. Heidi Crayton, joined...

2. • Clene (NASDAQ: CLNN) Issues Update on NIH-Funded Program for CNM-Au8(R) in ALS

     Digital Journal· 3 days ago

     CNM-Au8(R) is an investigational first-in-class therapy that improves central nervous system cells' survival and function via a mechanism that targets mitochondrial function and the NAD pathway ...

3. • 

     Wild Hogs Saloon host 2nd annual Muddin’ for MS event

     KCRG-TV9 Cedar Rapids· 6 days ago

     Michelle Jordan, owner of Wild Hogs said she started the ride in honor of her daughter who was...

4. • Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald

     Roanoke-Chowan News-Herald· 2 days ago

     This interview took place in conjunction with World MS Day, a day dedicated to raising global awareness about this debilitating disease. Vitt emphasized the significant unmet ...

5. • 

     Health Care Notes: Thyme Care scores venture investments

     Nashville Post· 1 day ago

     Nashville-based cancer care coordination company Thyme Care has announced it has received an...

6. • 

     Sudden Hearing Loss in One Ear: What You Need to Know and How to Seek Help

     Verywell Health via Yahoo News· 3 days ago

     Sudden hearing loss in one or both ears may indicate an infection, ear wax, a tumor, a head trauma,...

7. • Vanda Pharmaceuticals Announces Completion of Transfer of FDA Marketing Authorization for PONVORY®

     The Sun Chronicle· 2 days ago

     Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that ownership of the U.S. New Drug Application and Investigational New Drug Applications for PONVORY® (ponesimod) has been ...

8. • 

     Novartis reports Phase III data for trials of remibrutinib to treat CSU

     Clinical Trials Arena via Yahoo Finance· 1 day ago

     It is also being explored as a potential treatment for food allergy, chronic inducible urticaria,...

9. • 

     Cell therapy reckoning: Pivot to autoimmune leaves unmet need in oncology

     FierceBiotech· 2 days ago

     This story is part 2 in a four-part series about cell therapy created by the Fierce Biotech team....

10. • Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a...

      Morningstar· 2 days ago

      QALSODY is the first treatment approved in the European Union to target a genetic cause of ALS, also known as motor neuron disease (MND).